Results 111 to 120 of about 35,770,461 (338)
An extension of Nikishin's factorization theorem [PDF]
arXiv, 2016 A Nikishin-Maurey characterization is given for bounded subsets of weak-type Lebesgue spaces. New factorizations for linear and multilinear operators are shown to follow.
arxiv
A new method of calculating the scale factor in structure analysis [PDF]
, 1953 G. Kartha
openalex +1 more source
Molecular Oncology, EarlyView.In this explorative biomarker analysis, we assessed serial sampling of circulating tumor cells (CTCs) with CellSearch in two randomized trials testing immune checkpoint inhibitors (ICIs) in metastatic breast cancer. Our data demonstrate a prognostic potential of CTCs, most apparent 4 weeks into ICI therapy.
Nikolai Kragøe Andresen +13 more
wiley +1 more source
Revista Brasileira de Zootecnia, 1999 Com o objetivo de determinar a capacidade de combinação de linhagens de matrizes de corte, por meio da análise de fatores, cruzamentos (dialelo completo) dentro das linhagens fêmea (PP, KK e VV) foram usados.
Valéria Maria Nascimento Abreu +4 more
doaj
Constraints for non-zero secondary loadings in confirmatory factor analysis [PDF]
arXiv, 2015 In the context of confirmatory factor analysis, the independent clusters model has been found to be overly restrictive in several research contexts. Therefore, a less restrictive criterion for parsimony of non-salient loadings in confirmatory factor analysis was proposed.
arxiv
Circulating tumor cells: advancing personalized therapy in small cell lung cancer patients
Molecular Oncology, EarlyView.Small cell lung cancer (SCLC) is an aggressive form of lung cancer that spreads rapidly to secondary sites such as the brain and liver. Cancer cells circulating in the blood, “circulating tumor cells” (CTCs), have demonstrated prognostic value in SCLC, and evaluating biomarkers on CTCs could guide treatment decisions such as for PARP inhibitors ...
Prajwol Shrestha +6 more
wiley +1 more source
A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer
Molecular Oncology, EarlyView.Lung cancer cells were spiked into donor blood to evaluate the recovery rates of the following circulating tumor cell (CTC) enrichment technologies: CellMag™, EasySep™, RosetteSep™, Parsortix® PR1, and Parsortix® Prototype systems. Each method's advantages and disadvantages are described.
Volga M Saini +11 more
wiley +1 more source
نشریه پرستاری ایران, 2016 Background & Aim: Evaluation and measurement of mother’s satisfaction from postpartum cares is so important in the quality of health care indexes. The purpose of this study was to examine the psychometric properties of the Postpartum Satisfaction Nursing
H Horsan +3 more
doaj
Cell‐free and extracellular vesicle microRNAs with clinical utility for solid tumors
Molecular Oncology, EarlyView.Cell‐free microRNAs (cfmiRs) are small‐RNA circulating molecules detectable in almost all body biofluids. Innovative technologies have improved the application of cfmiRs to oncology, with a focus on clinical needs for different solid tumors, but with emphasis on diagnosis, prognosis, cancer recurrence, as well as treatment monitoring.
Yoshinori Hayashi +6 more
wiley +1 more source
Statistical properties of matrix decomposition factor analysis [PDF]
arXivFor factor analysis, numerous estimators have been developed, and most of their statistical properties are well understood. In the early 2000s, a novel estimator based on matrix factorization, called Matrix Decomposition Factor Analysis (MDFA for short), was developed.
arxiv